Corporate Profile
Cordlife Limited at a glance
Cordlife Limited is a leading healthcare company that provides a full suite of cord blood and tissue banking services to expectant parents for the collection, processing and cryopreservation of cord blood stem cells and umbilical cord tissue. The Company is dedicated to offering the highest possibility of successful adult stem cell therapy to give hope and save lives. Listed on the Australian Securities Exchange, Cordlife Limited is well established as the largest network of private stem cell banks across Asia Pacific with state-of-the-art cord blood and tissue processing and cryopreservation facilities in India, Indonesia and the Philippines as well as a network that extends to Singapore, Hong Kong, and China.
Expertise and quality you can trust
The Company’s in-depth knowledge of stem cell banking practices and standards is well recognized by numerous world-class quality standard organizations as well as country regulators in the Asia Pacific region. In 2007, Cordlife Limited was bestowed the prestigious “Technology Pioneer” title by the World Economic Forum which further validated the Company’s outstanding performance in the industry.
About Cordlife India
Cordlife India is the largest and most advanced cord blood facility in the country, with a storage capacity of up to 150,000 cord blood units. The state-of-the-art laboratory with full processing, testing and cryopreservation capabilities is equipped with continuous power back-up as well as the most-up-to-date security and surveillance systems. In addition, the building is specially designed to withstand any natural calamity.
Located in Kolkata and officially launched by Singapore Senior Minister and former Prime Minister Mr Goh Chok Tong, Cordlife India is licensed by the Drug Controller General of India to collect cord blood units from all Indian states and cities.
